PUBLISHER: BCC Research | PRODUCT CODE: 1266823
PUBLISHER: BCC Research | PRODUCT CODE: 1266823
The global central nervous system (CNS) biomarkers market should reach $9.5 billion by 2027 from $5.7 billion in 2022 at a compound annual growth rate (CAGR) of 10.8% for the forecast period of 2022 to 2027.
Life science research segment of the global CNS biomarkers market is expected to grow from $4.2 billion in 2022 to $6.8 billion in 2027 at a CAGR of 9.9% for the forecast period of 2022 to 2027.
Clinical diagnostics segment of the global CNS biomarkers market is expected to grow from $861.7 million in 2022 to $1.7 billion in 2027 at a CAGR of 14.3% for the forecast period of 2022 to 2027.
This study provides a comprehensive analysis of CNS biomarkers on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease subsegments to overall industry trends, in order to quantify and qualify the global CNS biomarkers market.
Current and projected product forecasts during the forecast period (2022 to 2027) are discussed. New products approved in 2021 and 2022 by the U.S. Food and Drug Administration (FDA), and those products expected to be approved within the forecast period are discussed. Market figures for 2022 are estimated, except where actual results have been reported.
Included in this report are forecasts by biomarker type, technology type, disease, application, and region from 2022 through 2027. The report also includes analysis of leading and emerging competitors in the current worldwide CNS biomarkers market. Profiles of manufacturers of leading products as well as biotechnology companies with novel products in development are analyzed to define the specific product strategies employed. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products and technologies are influencing the current standard of care.